Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.

Journal of cellular and molecular medicine - 1 Jan 2020

Wu Ran, Liu Chuanxu, Deng Xiaohui, Chen Linjun, Hao Siguo, Ma Liyuan

Abstract excerpt

Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is the only curative method in treating haematologic malignant diseases. Graft-versus-host disease (GVHD) is a common complication post-allo-HSCT, which can be life-threatening. Mesenchymal stem cells (MSCs) as an adult stem cell with immunoregulatory function have demonstrated efficacy in steroid resistant acute GVHD (aGVHD). However, the outcome of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Cell Polarity

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cell Shape

Share to Graft vs Host Disease

Share to Immunosuppression Therapy

Share to Mesenchymal Stem Cells

Share to T-Lymphocytes, Regulatory

Share to Transforming Growth Factor beta1

Source

Open in PubMed Open full text

Identifiers

PMID: 31782262
DOI: 10.1111/jcmm.14862
PMCID: PMC6991663

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.PMID 31782262Read ↗

Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targetsSemantic proximity Read ↗

Memory T cellsSemantic proximity Read ↗

Concurrent hypoxia and apoptosis imparts immune programming potential in mesenchymal stem cells: Lesson from acute graft-versus-host-disease modelSemantic proximity Read ↗

Synergistic Hypoxia and Apoptosis Conditioning Unleashes Superior Mesenchymal Stem Cells Efficacy in Acute Graft-versus-Host-DiseaseSemantic proximity Read ↗

Interleukin-22 Aggravates Murine Acute Graft-Versus-Host Disease by Expanding Effector T Cell and Reducing Regulatory T CellSemantic proximity Read ↗

Mesenchymal Stem Cells Direct the Immunological Fate of Macrophages.Semantic proximity Read ↗

Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.Semantic proximity Read ↗

Semaphorin 3A reduces the severity of aGVHD by promoting M2 macrophage polarizationSemantic proximity Read ↗

The immunomodulatory function of mesenchymal stem cells: mode of action and pathwaysSemantic proximity Read ↗

TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSESSemantic proximity Read ↗

hUC-EVs-ATO reduce the severity of acute GVHD by resetting inflammatory macrophages toward the M2 phenotype.Semantic proximity Read ↗

Exosomes originating from MSCs stimulated with TGF‐β and IFN‐γ promote Treg differentiationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.